Vimarsana
Biggest News Aggregation in the World

Oral Prep News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oral Prep. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oral Prep Today - Breaking & Trending Today

Aids killed one person per minute last year, UN report says - Vimarsana News

Aids killed one person per minute last year, UN report says

UNAIDS pointed out that HIV programmes succeed when public health priorities prevail, as experiences in multiple countries attest.

Young women prefer vaginal ring to daily oral pill for HIV prevention - Vimarsana News

Young women prefer vaginal ring to daily oral pill for HIV prevention

Study showed that having a range of options makes it more likely of there being one that will meet an individual’s needs and preferences and that it can and will be used.

ViiV Healthcare announces US FDA approval of Apretude (cabotegravir extended-release injectable suspension), the first and only long-acting injectable option for HIV prevention - Vimarsana News

ViiV Healthcare announces US FDA approval of Apretude (cabotegravir extended-release injectable suspension), the first and only long-acting injectable option for HIV prevention

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. (Pfizer) and Shionogi Limited (Shionogi) as shareholders, today announced that the US Food and Drug Administration (FDA) approved Apretude, the first and only long-acting injectable pre-exposure prophylaxis (PrEP) option to reduce the risk of sexually acquired HIV-1.